This project was sponsored by the American Nephrology Nurses Association (ANNA). The ANNA 2020-2021 Venous Needle Dislodgement Task Force would like thank the ANNA 2012 Venous Needle Dislodgement Task Force for their foundational work on which this current work builds. Funding for the printing and mailing of tools (Tool Kit, Taping Techniques, Risk Assessment, Minimizing VND Risk poster, Patient Education poster) was provided by Redsense Medical.
Contact hours available until 8/31/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online NCPD evaluation.
Nephrology Nursing Journal Editorial Board Statements of Disclosure:
In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each nursing continuing professional development offering. The statements of disclosure for this offering are published below.
Paula Dutka, MSN, RN, CNN, disclosed that she is a consultant for Rockwell Medical.
All other members of the Editorial Board had no actual or potential conflict of interest in relation to this nursing continuing professional development education activity.
The authors reported no actual or potential conflict of interest.
This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAONL, FAAN, Nephrology Nursing Journal Editor-in-Chief, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.
The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP17499.
This NCPD article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.
Upon completion of this learning activity, the nephrology nurse will utilize tools and information to minimize the risk of venous needle dislodgement and ABLS in hemodialysis settings.
Joan Speranza-Reid, MHA, RN
Deborah Brouwer, RN, CNN, Director, Clinical Business Development , Renal Solutions Inc.
Christina M. Cruz, MS, A-GNP-C
Michele Inglese, MSN, RN